AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
157.90
-0.43 (-0.27%)
Jul 11, 2025, 4:00 PM - Market closed
AptarGroup Revenue
AptarGroup had revenue of $887.31M in the quarter ending March 31, 2025, a decrease of -3.07%. This brings the company's revenue in the last twelve months to $3.55B, up 0.34% year-over-year. In the year 2024, AptarGroup had annual revenue of $3.58B with 2.74% growth.
Revenue (ttm)
$3.55B
Revenue Growth
+0.34%
P/S Ratio
2.95
Revenue / Employee
$263,315
Employees
13,500
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.58B | 95.44M | 2.74% |
| Dec 31, 2023 | 3.49B | 165.20M | 4.97% |
| Dec 31, 2022 | 3.32B | 95.03M | 2.94% |
| Dec 31, 2021 | 3.23B | 297.88M | 10.17% |
| Dec 31, 2020 | 2.93B | 69.61M | 2.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ATR News
- 2 days ago - Aptar Declares Quarterly Dividend - Business Wire
- 17 days ago - Aptar Named One of the World's Most Sustainable Companies by TIME for Second Consecutive Year - Business Wire
- 5 weeks ago - Aptar to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Aptar Releases 2024 Corporate Sustainability Report - Business Wire
- 2 months ago - AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aptar Reports First Quarter 2025 Results - Business Wire
- 3 months ago - Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Business Wire
- 3 months ago - AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds - Seeking Alpha